Chemify

Chemify is pioneering the digitization of chemistry through its integrated 'Chemputation' platform, which combines AI-driven molecular design, a universal chemical programming language (χDL), and advanced robotics for automated synthesis. Founded by Professor Lee Cronin based on decades of research, the company operates from Glasgow, Scotland, and has established an automated synthesis facility, the 'Chemifarm.' Its core value proposition is accelerating and de-risking the molecule creation process by closing the loop between digital design and physical synthesis, targeting significant productivity gains for drug and material discovery.

Chemputation: An integrated platform combining ML-based molecular design ('Quantum Chemputation'), route optimization software ('ASSEMBLER'), a universal chemical programming language ('χDL'), and advanced robotics for automated synthesis. It enables closed-loop Design-Make-Test-Analyze cycles.

Chemify competes in the AI for drug discovery space against companies like Exscientia, Recursion, and Insilico Medicine. Its key differentiation is the deep integration of its AI with a proprietary chemical programming language and dedicated robotics for physical synthesis, aiming to close the loop between digital design and physical molecule creation more completely than software-only competitors.